Retired autism researcher Robert Hendren, who conducted a study of leucovorin.Courtesy Nicholas Roznovsky In the realm of autism treatment, the conversation surrounding leucovorin has gained traction primarily through the enthusiastic…

Subscribe Now for Real-time Updates on the Latest Stories!
In a recent turn of events, a lawsuit filed by the Texas attorney general against the makers of Tylenol has…
The Trump administration is reportedly in the final stages of negotiations with pharmaceutical giants Eli Lilly and Novo Nordisk to…
The U.K.'s National Institute for Health and Care Excellence (NICE) is considering raising the cost-effectiveness threshold for the first time…
The Children's Hospital Association, a prominent organization representing over 200 hospitals, has unveiled a new strategy in response to the…
A groundbreaking approach in autoimmune therapy is targeting the B-cell pathway using bispecific antibodies. This innovative strategy builds on years…
Healthcare innovation is often associated with high-tech solutions and big budgets. However, a new trend is emerging in the industry—micro-innovation.…
The Trump administration has announced that it will partially fund the Supplemental Nutrition Assistance Program (SNAP) for November, following a…
In the late 1960s, a groundbreaking discovery was made in the field of medicine - a drug called levodopa was…
Sign in to your account